Revisiting the Ghrelin Changes Following Bariatric and Metabolic Surgery.
Bariatric/metabolic surgery
Comorbidity resolution
Diet-induced obesity
Ghrelin
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
pubmed:
24
4
2020
medline:
15
4
2021
entrez:
24
4
2020
Statut:
ppublish
Résumé
Since the description of ghrelin in 1999, several studies have dug into the effects of this hormone and its relationship with bariatric surgery. While some aspects are still unresolved, a clear connection between ghrelin and the changes after metabolic surgery have been established. Besides weight loss, a significant amelioration in obesity-related comorbidities following surgery has also been reported. These changes in patients occur in the early postoperative period, before the weight loss appears, so that amelioration may be mainly due to hormonal changes. The purpose of this review is to go through the current body of knowledge of ghrelin's physiology, as well as to update and clarify the changes that take place in ghrelin concentrations following bariatric/metabolic surgery together with their potential consolidation to outcomes.
Identifiants
pubmed: 32323063
doi: 10.1007/s11695-020-04601-5
pii: 10.1007/s11695-020-04601-5
doi:
Substances chimiques
Ghrelin
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM